vs

Side-by-side financial comparison of CYTOKINETICS INC (CYTK) and LIGHTPATH TECHNOLOGIES INC (LPTH). Click either name above to swap in a different company.

CYTOKINETICS INC is the larger business by last-quarter revenue ($17.8M vs $16.4M, roughly 1.1× LIGHTPATH TECHNOLOGIES INC). LIGHTPATH TECHNOLOGIES INC runs the higher net margin — -57.5% vs -1030.9%, a 973.4% gap on every dollar of revenue. On growth, LIGHTPATH TECHNOLOGIES INC posted the faster year-over-year revenue change (120.2% vs 4.9%). LIGHTPATH TECHNOLOGIES INC produced more free cash flow last quarter ($2.0M vs $-148.3M).

Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.

LightPath Technologies Inc designs, manufactures and distributes high-precision optical components and assemblies, including aspheric lenses, infrared optics, and fiber optic products. It serves global clients across industrial automation, aerospace, defense, medical imaging, and telecommunications sectors.

CYTK vs LPTH — Head-to-Head

Bigger by revenue
CYTK
CYTK
1.1× larger
CYTK
$17.8M
$16.4M
LPTH
Growing faster (revenue YoY)
LPTH
LPTH
+115.3% gap
LPTH
120.2%
4.9%
CYTK
Higher net margin
LPTH
LPTH
973.4% more per $
LPTH
-57.5%
-1030.9%
CYTK
More free cash flow
LPTH
LPTH
$150.3M more FCF
LPTH
$2.0M
$-148.3M
CYTK

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
CYTK
CYTK
LPTH
LPTH
Revenue
$17.8M
$16.4M
Net Profit
$-183.0M
$-9.4M
Gross Margin
36.8%
Operating Margin
-1004.6%
-52.6%
Net Margin
-1030.9%
-57.5%
Revenue YoY
4.9%
120.2%
Net Profit YoY
-22.0%
-260.1%
EPS (diluted)
$-1.51
$-0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CYTK
CYTK
LPTH
LPTH
Q4 25
$17.8M
$16.4M
Q3 25
$15.1M
Q2 25
$66.8M
$12.2M
Q1 25
$9.2M
Q4 24
$16.9M
$7.4M
Q3 24
$8.4M
Q2 24
$8.6M
Q1 24
$7.7M
Net Profit
CYTK
CYTK
LPTH
LPTH
Q4 25
$-183.0M
$-9.4M
Q3 25
$-2.9M
Q2 25
$-134.4M
$-7.1M
Q1 25
$-3.6M
Q4 24
$-150.0M
$-2.6M
Q3 24
$-1.6M
Q2 24
$-2.4M
Q1 24
$-2.6M
Gross Margin
CYTK
CYTK
LPTH
LPTH
Q4 25
36.8%
Q3 25
29.8%
Q2 25
22.0%
Q1 25
29.1%
Q4 24
26.0%
Q3 24
33.9%
Q2 24
29.2%
Q1 24
20.9%
Operating Margin
CYTK
CYTK
LPTH
LPTH
Q4 25
-1004.6%
-52.6%
Q3 25
-16.6%
Q2 25
-167.0%
-38.0%
Q1 25
-36.3%
Q4 24
-821.4%
-33.5%
Q3 24
-16.4%
Q2 24
-25.6%
Q1 24
-33.6%
Net Margin
CYTK
CYTK
LPTH
LPTH
Q4 25
-1030.9%
-57.5%
Q3 25
-19.2%
Q2 25
-201.2%
-57.8%
Q1 25
-39.1%
Q4 24
-886.3%
-35.2%
Q3 24
-19.3%
Q2 24
-27.3%
Q1 24
-33.7%
EPS (diluted)
CYTK
CYTK
LPTH
LPTH
Q4 25
$-1.51
$-0.20
Q3 25
$-0.07
Q2 25
$-1.12
$0.19
Q1 25
$-0.44
Q4 24
$-1.26
$-0.07
Q3 24
$-0.04
Q2 24
$-0.15
Q1 24
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CYTK
CYTK
LPTH
LPTH
Cash + ST InvestmentsLiquidity on hand
$122.5M
$73.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$-659.6M
$77.9M
Total Assets
$1.4B
$148.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CYTK
CYTK
LPTH
LPTH
Q4 25
$122.5M
$73.6M
Q3 25
Q2 25
$74.9M
$4.9M
Q1 25
Q4 24
$94.9M
Q3 24
Q2 24
Q1 24
Total Debt
CYTK
CYTK
LPTH
LPTH
Q4 25
Q3 25
Q2 25
$609.7M
Q1 25
Q4 24
$619.5M
Q3 24
Q2 24
$535.0K
Q1 24
$599.4K
Stockholders' Equity
CYTK
CYTK
LPTH
LPTH
Q4 25
$-659.6M
$77.9M
Q3 25
$21.4M
Q2 25
$-368.7M
$15.6M
Q1 25
$15.7M
Q4 24
$-135.4M
$26.7M
Q3 24
$29.4M
Q2 24
$30.2M
Q1 24
$31.7M
Total Assets
CYTK
CYTK
LPTH
LPTH
Q4 25
$1.4B
$148.6M
Q3 25
$87.3M
Q2 25
$1.2B
$81.5M
Q1 25
$81.4M
Q4 24
$1.4B
$45.8M
Q3 24
$48.4M
Q2 24
$48.1M
Q1 24
$49.7M
Debt / Equity
CYTK
CYTK
LPTH
LPTH
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.02×
Q1 24
0.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CYTK
CYTK
LPTH
LPTH
Operating Cash FlowLast quarter
$-142.7M
$2.8M
Free Cash FlowOCF − Capex
$-148.3M
$2.0M
FCF MarginFCF / Revenue
-835.2%
12.0%
Capex IntensityCapex / Revenue
31.8%
5.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-438.9M
$-6.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CYTK
CYTK
LPTH
LPTH
Q4 25
$-142.7M
$2.8M
Q3 25
$-1.1M
Q2 25
$-128.2M
$-2.6M
Q1 25
$-3.2M
Q4 24
$-65.6M
$-737.4K
Q3 24
$-1.7M
Q2 24
$64.7K
Q1 24
$-394.2K
Free Cash Flow
CYTK
CYTK
LPTH
LPTH
Q4 25
$-148.3M
$2.0M
Q3 25
$-1.2M
Q2 25
$-132.4M
$-3.3M
Q1 25
$-3.7M
Q4 24
$-66.9M
$-817.8K
Q3 24
$-1.8M
Q2 24
$-225.5K
Q1 24
$-802.5K
FCF Margin
CYTK
CYTK
LPTH
LPTH
Q4 25
-835.2%
12.0%
Q3 25
-8.1%
Q2 25
-198.3%
-27.3%
Q1 25
-40.0%
Q4 24
-395.0%
-11.0%
Q3 24
-21.2%
Q2 24
-2.6%
Q1 24
-10.4%
Capex Intensity
CYTK
CYTK
LPTH
LPTH
Q4 25
31.8%
5.3%
Q3 25
0.5%
Q2 25
6.2%
5.6%
Q1 25
4.6%
Q4 24
7.6%
1.1%
Q3 24
0.9%
Q2 24
3.4%
Q1 24
5.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CYTK
CYTK

Other$9.1M51%
Collaboration Revenues$8.7M49%

LPTH
LPTH

Other$7.9M48%
Infrared Components$5.0M31%
Visible Components$3.4M21%

Related Comparisons